VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-00396
Package ID: USCOURTS-cofc-1_18-vv-00396
Petitioner: Sabrina Chappell-Strickland
Filed: 2018-03-15
Decided: 2021-03-30
Vaccine: MMR
Vaccination date: 2016-05-23
Condition: right shoulder injury
Outcome: compensated
Award amount USD: 57500

AI-assisted case summary:
Sabrina Chappell-Strickland filed a petition for compensation on March 15, 2018, alleging that a measles-mumps-rubella (MMR) vaccination she received on May 23, 2016, caused a right shoulder injury. The injury allegedly began within the timeframe specified by the Vaccine Injury Table and persisted for more than six months. The respondent, the Secretary of Health and Human Services, denied that the petitioner sustained a Table injury or that the vaccine caused her alleged injury. Despite maintaining their respective positions, the parties reached a stipulation to settle the case. Special Master Thomas L. Gowen adopted the stipulation, awarding Sabrina Chappell-Strickland $57,500.00. This award consisted of $55,000.00 for pain and suffering and $2,500.00 for past unreimbursed expenses. The decision was entered on March 30, 2021. Bridget C. McCullough of Muller Brazil, LLP, represented the petitioner, and Darryl R. Wishard represented the respondent. The public decision does not describe the specific onset of symptoms, medical tests, or treatments received by the petitioner.

Theory of causation field:
Petitioner Sabrina Chappell-Strickland received an MMR vaccination on May 23, 2016. She alleged a right shoulder injury, claiming it began within the Vaccine Injury Table timeframe and persisted for over six months, or alternatively, that the vaccine caused the injury. The respondent denied a Table injury or vaccine causation. The parties stipulated to a settlement, with Special Master Thomas L. Gowen adopting the stipulation. The award was $57,500.00 ($55,000.00 for pain and suffering, $2,500.00 for past unreimbursed expenses), entered March 30, 2021. Petitioner counsel was Bridget C. McCullough; respondent counsel was Darryl R. Wishard. The public decision does not detail the specific mechanism of injury or expert testimony.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_18-vv-00396-0
Date issued/filed: 2021-02-17
Pages: 13
Docket text: PUBLIC ORDER/RULING (Originally filed: 1/27/21) regarding 78 Findings of Fact & Conclusions of Law Signed by Special Master Thomas L. Gowen. (kb) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 1 of 13
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
Filed: January 27, 2021
* * * * * * * * * * * * * UNPUBLISHED
SABRINA CHAPPELL-STRICKLAND, *
* No. 18-396V
Petitioner, *
v. * Special Master Gowen
*
SECRETARY OF HEALTH * Findings of Fact; Measles-Mumps-Rubella
AND HUMAN SERVICES, * (MMR); Shoulder Injury Related to Vaccine
* Administration (SIRVA); Vaccine
* Administration Method; Subcutaneous
Respondent. * Versus Intramuscular.
* * * * * * * * * * * * *
Bridget C. McCullough, Muller Brazil, LLP, for petitioner.
Darryl R. Wishard, United States Department of Justice, Washington, DC, for respondent.
FINDINGS OF FACT1
On March 15, 2018, Sabrina Chappell-Strickland (“petitioner”), filed a petition for
compensation in the National Vaccine Injury Compensation Program.2 Petition (ECF No. 1).
Petitioner alleges as a result of a measle-mumps-rubella (MMR) vaccine administered in her
right arm on May 23, 2016, she developed pain and limited range of motion which lasted for
more than six months and involved surgical intervention. The following findings of fact pertain
to the MMR vaccine’s administration.3
1 Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this decision contains a
reasoned explanation for the action in this case, I am required to post it on the website of the United States Court of
Federal Claims. The court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. This means the
decision will be available to anyone with access to the Internet. Before the decision is posted on the court’s
website, each party has 14 days to file a motion requesting redaction “of any information furnished by that party:
(1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that
includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of
privacy.” Vaccine Rule 18(b). “An objecting party must provide the court with a proposed redacted version of the
decision.” Id. If neither party files a motion for redaction within 14 days, the decision will be posted on the
court’s website without any changes. Id.
2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine
Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended 42 U.S.C. §§ 300aa-10 to 34 (2012)
(hereinafter “Vaccine Act” or “the Act”). Hereinafter, individual section references will be to 42 U.S.C. § 300aa of
the Act.
3 Pursuant to § 300aa-13(a)(1), in order to reach my conclusion, I considered the entire record. This opinion
discusses the elements of the record I found most relevant to the outcome.

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 2 of 13
I. Relevant Procedural History
In March 2018, petitioner filed the petition accompanied by her exhibits (Pet. Exs.) 1-8
(ECF No. 1). This batch of records included Duke Primary Care’s immunization history report
listing the MMR vaccine at issue at Pet. Ex. 1, Duke Primary Care records at Pet. Ex. 3, and
petitioner’s initial affidavit at Pet. Ex. 8.
The claim was originally assigned to the Chief Special Master’s Special Processing Unit
(SPU), which is designed to expedite the processing of claims that have historically been
resolved without extensive litigation. On March 19, 2018, the Chief Special Master ordered
petitioner to file any outstanding medical records and a statement of completion. See SPU Initial
Order filed March 19, 2018 (ECF No 5). On March 28, 2018, petitioner filed a motion for
extension of time to complete her filings. Pet. Motion (Mot.) (ECF No. 6). Specifically,
petitioner’s counsel had identified “deficiencies in the immunization record” and had requested a
“comprehensive immunization record”. Id.; see also Pet. Mot. to Issue Subpoena filed April 25,
2018 (ECF No. 9). These motions were granted. On May 14, 2018, petitioner filed another
record of the MMR vaccination, not from Duke Primary Care but from the North Carolina
Immunization Registry (NCIR). Pet. Ex. 9 (ECF No. 13).
A staff attorney acting on behalf of the Chief Special Master held an initial status
conference with counsel. See Scheduling Order filed May 21, 2018 (ECF No. 14). Petitioner
filed a second affidavit. Pet. Ex. 10 filed June 8, 2018 (ECF No. 15); see also Statement of
Completion filed July 12, 2018 (ECF No. 16).
On November 27, 2018, respondent filed his report pursuant to Vaccine Rule 4(c), in
which respondent recommended that compensation be denied for this claim. Respondent’s
Report (Resp. Rep’t) (ECF No. 22). Most relevant to the instant finding of fact, respondent
noted that the effective version of the Vaccine Injury Table creates a presumption of causation if
a petitioner establishes that after receiving an MMR vaccine, she developed a shoulder injury
related to vaccine administration (SIRVA) with the onset of pain within forty-eight (48) hours.
See Resp. Rep’t at 4-5 (referencing 82 Fed. Reg. 6294 (Jan. 19, 2017); 42 C.F.R. § 100.3(c)).
However, the Vaccine Injury Table only recognizes SIRVA following “administration of a
vaccine intended for intramuscular administration in the upper arm”. Resp. Rep’t at 4-5; see
also 42 C.F.R. § 100.3(c)(10). Respondent averred that in this case, the medical records provide
that petitioner received the MMR vaccine at issue subcutaneously in her right arm. Resp. Rep’t
at 2 (citing Pet. Ex. 3 at 9 (the immunization history form which does not specify a method of
administration), Pet. Ex. 9 at 2 (the NCIR record)). Respondent averred that based on these
records, petitioner’s injury is not consistent with SIRVA as defined on the Vaccine Injury Table
and she is limited to alleging causation-in-fact. Resp. Rep’t at 4-5.
After reviewing respondent’s report, the Chief Special Master determined that the claim
was no longer appropriate for the SPU and it was reassigned to my docket. See Order
Reassigning Case filed November 28, 2018 (ECF No. 23); Scheduling Order filed December 11,
2018 (ECF No. 25).4
4 Initially, petitioner and/or her counsel did not dispute the medical records reflecting that the MMR vaccine was
administered subcutaneously. See, e.g., Pet. Exs. 8, 10, 11; Scheduling Order filed December 11, 2018 (ECF No.
2

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 3 of 13
Petitioner filed her third affidavit. Pet. Ex. 11 filed January 24, 2019 (ECF No. 29).
Petitioner filed selected Facebook posts referring to the May 23, 2016 medical encounter, the
vaccinations, and her subsequent shoulder pain, as well as her husband James Strickland’s
affidavit. Pet. Exs. 17-18 filed May 4, 2020 (ECF No. 47).
During a status conference on August 4, 2020, petitioner’s counsel, citing the Facebook
posts and the husband’s affidavit, expressly raised the argument that the MMR vaccine was
administered improperly. Petitioner’s counsel referenced a third vaccine administration record.
It was agreed that petitioner would file additional evidence and then a fact hearing would be
convened. Scheduling Order filed August 7, 2020 (ECF No. 57).
Petitioner then filed comprehensive vaccination records from Duke Primary Care. Pet.
Ex. 29 filed August 10, 2020 (ECF No. 58). At respondent’s request, petitioner filed all of her
Facebook posts dating from November 1, 2015 – December 31, 2016. Pet. Ex. 30 filed
September 1, 2020 (ECF No. 60). She filed affidavits from Amrit Gill M.D.5 and two medical
assistants (MAs), Tracie Collins and Rachida Guerrab, whose names appeared on the Duke
Primary Care records. Pet. Exs. 31-33 filed November 6, 2020 (ECF No. 71); Pet. Ex. 34 filed
November 7, 2020 (ECF No. 73).
A fact hearing was held via videoconference on November 13, 2020. The witnesses were
petitioner, James Strickland, Dr. Amrit Gill, MA Tracie Collins, and MA Rachida Guerrab.6 At
the end of the hearing, counsel and I agreed to review the transcript and then discuss further
proceedings at a future status conference. See Transcript (Tr.) filed December 11, 2020 (ECF
No. 76). During that status conference on January 22, 2021, the parties did not request oral
argument or written briefing. They requested to hear my preliminary findings of fact, which I
offered and are finalized herein. Counsel agreed to review these findings of fact with their
respective clients and then propose further proceedings.
II. Legal Standard
Pursuant to Vaccine Act § 13(a)(1)(A), a petitioner must prove, by a preponderance of
the evidence, the matters required in the petition by Vaccine Act § 11(c)(1). A special master
must consider, but is not bound by, any diagnosis, conclusion, judgment, test result, report, or
summary concerning the nature, causation, and aggravation of petitioner’s injury or illness that is
contained in a medical record. § 13(b)(1). “Medical records, in general, warrant consideration
25); Scheduling Order filed February 26, 2020 (ECF No. 45). Thus, I authorized petitioner to seek expert opinion(s)
as to whether a properly administered MMR vaccine can and did cause her injuries. Petitioner obtained supportive
reports from an immunologist and from her treating orthopedist, to which respondent responded. While I have
reviewed these reports, they do not help to resolve the factual dispute about how petitioner’s MMR vaccine was
administered.
5 The medical records reflect that in 2016, the primary care provider’s name was Dr. Amrit Manes. At the fact
hearing in 2020, it was confirmed that her current last name is Gill. This opinion consistently refers to Dr. Amrit
Gill.
6 Colleen Yopp, an ambulatory risk services manager for Duke Primary Care, was also present during the testimony
of MA Collins, Dr. Gill, and MA Guerrab. See Tr. 2, 105, 147, 191.
3

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 4 of 13
as trustworthy evidence. The records contain information supplied to or by health professionals
to facilitate diagnosis and treatment of medical conditions. With proper treatment hanging in the
balance, accuracy has an extra premium. These records are also generally contemporaneous to
the medical events.” Curcuras v. Sec’y of Health & Human Servs., 993 F.2d 1525, 1528 (Fed.
Cir. 1993).
Accordingly, where medical records are clear, consistent, and complete, they should be
afforded substantial weight. Lowrie v. Sec’y of Health & Human Servs., No. 03-1585V, 2005
WL 6117475, at *20 (Fed. Cl. Spec. Mstr. Dec. 12, 2005). However, this rule does not always
apply. In Lowrie, the special master wrote that “written records which are, themselves,
inconsistent, should be accorded less deference than those which are internally consistent.”
Lowrie, at *19.
The United States Court of Federal Claims has recognized that “medical records may be
incomplete or inaccurate.” Camery v. Sec’y of Health & Human Servs., 42 Fed. Cl. 381, 391
(1998). The Court later outlined four possible explanations for inconsistencies between
contemporaneously created medical records and later testimony: (1) a person’s failure to recount
to the medical professional everything that happened during the relevant time period; (2) the
medical professional’s failure to document everything reported to her or him; (3) a person’s
faulty recollection of the events when presenting testimony; or (4) a person’s purposeful
recounting of symptoms that did not exist. La Londe v. Sec’y of Health & Human Servs., 110
Fed. Cl. 184, 203-04 (2013), aff’d, 746 F.3d 1335 (Fed. Cir. 2014).
The Court has also said that medical records may be outweighed by testimony that is
given later in time that is “consistent, clear, cogent, and compelling.” Camery, 42 Fed. Cl. at 391
(citing Blutstein v. Sec’y of Health & Human Servs., No. 90-2808, 1998 WL 408611, at *5 (Fed.
Cl. Spec. Mstr. June 30, 1998). The credibility of the individual offering such testimony must
also be determined. Andreu v. Sec’y of Health & Human Servs., 569 F.3d 1367, 1379 (Fed. Cir.
2009); Bradley v. Sec’y of Health & Human Servs., 991 F.2d 1570, 1575 (Fed. Cir. 1993).
The special master is obligated to fully consider and compare the medical records,
testimony, and all other “relevant and reliable evidence contained in the record.” La Londe, 110
Fed. Cl. at 204 (citing § 12(d)(3); Vaccine Rule 8); see also Burns v. Sec’y of Health & Human
Servs., 3 F.3d 415, 417 (Fed. Cir. 1993) (holding that it is within the special master’s discretion
to determine whether to afford greater weight to medical records or to other evidence, such as
oral testimony surrounding the events in question that was given at a later date, provided that
such determination is rational).
III. Discussion
A. Proper Vaccine Administration
The factual issue to be resolved is whether petitioner’s May 23, 2016, MMR vaccination
was properly administered subcutaneously.
4

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 5 of 13
Respondent filed a fact sheet7 which addresses proper administration of various vaccines.
Resp. Ex. E-29. For example, the method varies for different zoster (shingles) vaccines:
Shingrix should be administered intramuscularly while Zostavax should be administered
subcutaneously. Id. In contrast, tetanus-diphtheria-acellular pertussis (Tdap) vaccines should
always be administered intramuscularly. Id. MMR vaccines should always be administered
subcutaneously. Id.
A medical provider administering an intramuscular (IM) injection should use a 22 –
25 gauge needle. Resp. Ex. E-29. The proper needle length varies based on the vaccinee’s
weight. It can be as short as 5/8” for a female or male less than 130 pounds, 1” inch for
individuals of more average weights, and up to 1 ½” inches for a female greater than 200 pounds
or a male greater than 260 pounds. Id. The injection should be made into the deltoid muscle of
the arm and should resemble the illustration below:
In contrast, a medical provider administering a subcutaneous (SQ) injection should use a
23 – 25 gauge needle. Resp. Ex. E-29. The proper needle length is always 5/8”, regardless of
the vaccinee’s weight or any other factors. Id. The injection should be made into the back of the
arm, specifically the fatty tissue over the triceps, and should resemble the illustration below:
7 Immunization Action Coalition, Dose, Route, Site, and Needle Size, at www.immunize. org/catg.d/p3085.pdf
[Resp. Ex. E-29]. The Centers for Disease Control and Prevention (CDC) “work[s] in concert and provide[s]
financial support” to this coalition, which runs several websites. The website cited by respondent is intended as a
“non-profit web-based resource” for healthcare professionals. See Immunization Action Coalition, About Us, at
https://www.immunize.org/aboutus/ (last accessed January 25, 2020).
5

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 6 of 13
In the Rule 4(c) report, respondent adds that during administration of a subcutaneous vaccine, the
medical provider “pinch[es]” the skin to insert the needle. Resp. Rep’t at n. 1. I also located the
specific MMR vaccine package insert which is consistent with the above explanation. See
Scheduling Order and Ct. Ex. 1 filed August 7, 2020 (ECF No. 57).
B. Factual Record
I have completed a review of the record to include all medical records, affidavits,
testimony, respondent’s Rule 4(c) report, and additional evidence filed. I found the following
factual evidence to be most relevant to resolution of this issue:
• The medical record which provides that on May 23, 2016, petitioner presented to a Duke
Primary Care in Morrisville, North Carolina to establish a new primary care relationship
and to receive Tdap and MMR vaccines which were required for her college enrollment.
Dr. Amritpal Gill conducted a well-adult examination. Pet. Ex. 3 at 5-9. At 8:37 a.m.,
Dr. Gill entered orders for Tdap (IM) and MMR (SQ) vaccines. Id. at 10. At 9:05 a.m.,
Dr. Gill entered an order for a pregnancy test on account of “irregular periods”. Id. at 11.
At 9:26 a.m., the result was recorded as negative. Id. At 10:00 a.m., medical assistant
Tracie Collins (discussed further below) entered another order for “possible pregnancy”
which Dr. Gill authorized, then discontinued for being duplicative. Id.
• Dr. Gill’s initial entry on May 23, 2016, which provides that petitioner would be
receiving a Tdap vaccine intramuscularly into the left deltoid, but the status was
“incomplete”. Pet. Ex. 29 at 7. That same day, MA Tracie Collins added the
manufacturer, brand name, lot number, batch number, and expiration date. Id. MA
Collins also recorded that she administered the Tdap vaccine. Id.
• Dr. Gill’s initial entry on May 23, 2016, which provides that petitioner would be
receiving an MMR vaccine manufactured by Merck & Co. subcutaneously into the left
deltoid. Pet. Ex. 29 at 8-9. That same day, MA Rachida Guerrab added the brand name,
lot number, batch number, and expiration date. Id. at 8. Then, MA Collins changed the
site to “right arm” and recorded that she administered the MA vaccine. Id.
• The NCIR entry which provides that on May 23, 2016, Dr. Gill ordered and MA Collins
administered a MMR vaccine subcutaneously into petitioner’s right arm. Pet. Ex. 9 at 2.
• The medical record which provides that on August 15, 2016, petitioner returned to Dr.
Gill with a new complaint of right shoulder pain and limited range of motion. Petitioner
was concerned that these symptoms were related to the MMR vaccine which was
administered in that same arm. Dr. Gill prescribed Tramadol for pain and referred
petitioner to orthopedic surgery. Dr. Gill did not address how the vaccine was
administered. Pet. Ex. 3 at 40-46.
• The medical record which provides that on October 26, 2016, petitioner presented to an
orthopedist, Joseph Wilson, M.D. for a chief complaint of a right shoulder injury
6

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 7 of 13
beginning after the MMR vaccine. Dr. Wilson did not address how the vaccine was
administered. Pet. Ex. 4 at 12-14.
• The medical record which provides that on November 8, 2016, an MRI of petitioner’s
right shoulder visualized signal changes that were consistent with tendinosis and a
possible partial articular surface interstitial tear. No full-thickness rotator cuff tear was
noted, however. The rotator cuff muscle bulk was preserved and the long head of the
biceps tendon appeared intact. The MRI also visualized significant subacromial bursitis,
arthrofibrosis encompassing the glenohumeral joint, inflammation encompassing the
entirety of the bicep tendon, and significant inflammation at the superior labrum with a
SLAP tear. Pet. Ex. 4 at 7-11.
• The medical record which provides that on December 7, 2016, Dr. Wilson wrote that the
MRI findings were consistent with a partial thickness supraspinatus rotator cuff surface
tear less than 50%, a non-displaced type II slap tear, significant subacromial bursitis, and
AC joint arthritis. Pet. Ex. 4 at 10-11.
• The operative note which provides that on December 13, 2016, Dr. Wilson performed
surgical intervention on petitioner’s right shoulder. He recorded that the rotator cuff was
completely intact. More significantly, Dr. Wilson noted inflammation of the biceps
tendon at its insertion into the superior labrum and that the medial sling of the biceps
tendon was torn. He performed a right shoulder arthroscopic lysis of adhesions,
subacromial decompression, biceps tenodesis, distal clavicle excision, and manipulation
under anesthesia to regain full range of motion. Pet. Ex. 7 at 4-5.
• The medical records which provide that following her surgery, petitioner followed up
with Dr. Wilson and participated in physical therapy. Pet. Ex. 4 at 5-6; see generally Pet.
Ex. 6).
• I have also reviewed petitioner’s Facebook posts. Of note, on May 23, 2016, petitioner
posted that she had went through “shenanigans” to get her vaccines. She didn’t “even
know where to begin, but how about the nurse put on her sterile gloves then went on
about touching everything in the room before trying to give [petitioner] a shot”. Pet. Ex.
30 at 380. Petitioner added that her “arm was killing [her]”. Id.
• On September 11, 2016, petitioner posted that she was looking for an attorney and
learning how the “needle used to administer” a vaccine can cause shoulder injury. Pet.
Ex. 30 at 567.
• On October 7, 2016, petitioner posted, in response to a friend’s question of how her
shoulder was injured, that: “[T]he nurse… put the needle too high in my arm when giving
me a vaccine. An hour later, my arm stopped working.” Pet. Ex. 30 at 625.
• On December 12, 2016, the day before her shoulder surgery, petitioner wrote a lengthy
post recounting what occurred on May 23, 2016, including that “the nurse neglected to
ask if [petitioner] might be pregnant”, “the nurse” had to be reminded to put on sterile
7

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 8 of 13
gloves, and that as “the nurse” was administering a vaccine, a supervisor observed that
the needle was “not a subderm needle”. Pet. Ex. 30 at 770.
• I have also reviewed petitioner and her husband’s later, more detailed recollections of the
vaccinations on May 23, 2016. For background, the husband was present for the entire
medical appointment. He was sitting in a chair on the right side of the room. Tr. 67.
Petitioner was sitting on a table in the center of the examination room. Tr. 8, 66-67.
• Dr. Gill conducted the medical evaluation and left. Then, MA Tracie Collins prepared to
administer the Tdap and MMR vaccines. Tr. 7.
• The husband recalled that compared to petitioner who is 5”10’ tall (see Pet. Ex. 3 at 6)
and was sitting on a table, MA Collins was much shorter. See Pet. Ex. 18; Tr. 67.
• Petitioner and her husband recalled that when MA Collins was preparing to administer
the Tdap vaccine, she briefly left the room. When she came back in, they reminded her
to wash her hands and put on sterile gloves. Tr. 8, 66-67.
• Petitioner recalled that MA Collins then administered the Tdap vaccine into the “front
side of [petitioner’s left] arm, about halfway up the bicep”. Tr. 9. She did not pinch the
skin of the arm. Tr. 44-45. The husband recalled that because MA Collins was relatively
short and petitioner was sitting straight up on the examination table, MA Collins wasn’t
quite at the level that she needed to be to administer the vaccination at a perpendicular
(90 degree) angle. Tr. 68. She seemed to inject the needle “upwards at an angle”,
“diagonally”, rather than going “straight into the arm”. Tr. 68. The husband estimated
that for both vaccines, the angle was between 30 to 45 degrees; it was “not
perpendicular” with the skin. Tr. 98-99.
• Petitioner and her husband recalled that MA Collins started preparing the MMR vaccine,
then paused to ask petitioner whether she could be pregnant, which petitioner answered
was possible. Petitioner then left the examination room to take a pregnancy test.
Petitioner returned to the examination room and to her position on the table. Dr. Gill
came back to state that the pregnancy test was negative, then left again. Tr. 10, 69-70.
• Petitioner recalled that MA Collins stood “in front” to administer the MMR vaccine. Tr.
11. The husband recalled that MA Collins was standing at petitioner’s front right-hand
side of petitioner. The husband was seated slightly beside them both against the wall.
MA Collins, petitioner, and the husband formed a triangle. Tr. 71, 94.
• Petitioner recalled that MA Colins then cleaned and sterilized her right arm for the MMR
vaccine. Tr. 10. She pinched the skin of the right arm with two fingers. Tr. 11, 44.
• Petitioner recalled that MA Collins administered the MMR vaccine “a little bit higher”
than the Tdap vaccine based on where she placed the bandages. Tr. 11-12.
8

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 9 of 13
• Petitioner pointed at where the MMR vaccine was administered on her arm, which I
observed to be “roughly where the deltoid muscle is” in the “upper middle lateral section
of the arm”. Tr. 14. On cross-examination, petitioner indicated that compared to the
Tdap vaccine, the MMR vaccine was given higher in the arm. The MMR vaccine was
also given on the outside of the arm and centrally in the arm. Tr 45-46. I understood
petitioner’s testimony to be that although MA Collins pinched her skin, MA Collins
administered the vaccine high into the deltoid area of the arm and not on the posterior
underside of the arm near the triceps.
• The husband recalled that the MMR vaccine was administered at an angle. As noted
above, he estimated that the angle was between 30 to 45 degrees; it was “not
perpendicular” with the skin. Tr. 98-99.
• Petitioner recalled that as MA Collins was injecting the MMR vaccine, another medical
professional looked into the room and remarked that MA Collins was using the wrong
needle. Both medical professionals briefly left the room and then MA Collins came back.
However, petitioner did not provide a name or any further identification of this person.
Tr. 11-12. Her husband provided similar testimony. Tr. 66, 71-72, 77-78.
• Petitioner recalled that upon returning to the examination room, MA Collins advised that
it would be normal to expect pain from the MMR vaccine for up to two months. Tr. 12.
• I have also reviewed the testimony of the vaccine administrator Tracie Collins. She
obtained an associates degree in health science and completed a program to become a
medical assistant in 2015. She became licensed as both a certified medical assistant
(CMA) and registered medical assistant (RMA) in early 2016. She was unable to explain
the difference, if any, between the two designations. Duke Primary Care hired MA
Collins for her first job in that profession in April 2016. She underwent orientation and
training throughout the summer of 2016. Tr. 106-08; see also Pet. Ex. 34 at ¶¶ 3-5. In
December 2019, she transitioned from being partially “on the floor” assisting with
patients to working exclusively in the lab at Duke Primary Care. Tr. 106, 111, 131-32.
• MA Collins testified that while the medical records list her name as the administrator of
the Tdap and MMR vaccines petitioner received on May 23, 2016, she did not have any
independent recollections of those events or having otherwise met petitioner. Tr. 124-25;
see also Pet. Ex. 34 at ¶¶ 12-15.
• MA Collins testified that she would receive a printout of the patient’s information, verify
that information by speaking with the patient, and do some dictation and/or entry into the
electronic medical record. She would administer the vaccine(s) and then record that it
was complete. Tr. 121-23. On cross-examination, respondent’s counsel asked, referring
to Pet. Ex. 29 at 8, “Now, I know you can’t recall this specific case, but in terms of this
document is created, is there some type of drop-down menu in the system where you
would fill these blanks in regarding date and status?”. Tr. 126-27. MA Collins agreed.
Tr. 127. She also testified that some of the columns populated on their own once the lot
number and the NDC number were entered. Tr. 128-29.
9

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 10 of 13
• MA Collins testified that in general, a Tdap vaccine should be administered
intramuscularly into the deltoid. She testified that to find the correct spot, she would
place a thumb on about the end of the acromion, “and then two fingers and then you
would spread between the second and ring finger… and then give the injection in
between the second and ring finger.” The injection should be at a 90-degree angle. Tr.
112-14; see also Pet. Ex. 34 at ¶ 8. MA Collins stated that the proper needle width
should be 25-gauge, but she could not state the proper needle length. She seemed to
agree that there was a “standard” length. She stated that she would use the same type of
needle regardless of the vaccinee’s size. Tr. 114-17.
• MA Collins testified that in general, an MMR vaccine should be administered
subcutaneously into the “fatty part of the arm, which is more on the back of the arm”.
MA Collins agreed that as opposed to using the measuring technique she described for
the Tdap vaccine, she would “kind of just push up with one hand” to administer the
MMR vaccine at a 45-degree angle. Tr. 117-19; see also Pet. Ex. 34 at ¶ 9. She stated
that for Tdap versus MMR, there was no difference in needle width or length. Tr. 119,
121. She did not administer MMR vaccines to adults very often. Tr. 119-20.
• I have also reviewed the testimony of Rachida Guerrab, who obtained her CMA license
in 2013 and was employed at Duke Primary Care from 2014 until October 2018. Pet. Ex.
31 at ¶¶ 2, 4; Tr. 167-69. Since January 2019, MA Guerrab has been employed at a
neurology practice, where she does not administer any vaccines. Tr. 167, 188-89.
• As noted above, MA Guerrab entered the brand name, lot number, batch number, and
expiration date into the MMR vaccine administration record, before MA Collins actually
gave the vaccine. See Pet. Ex. 29 at 8. However, MA Guerrab did not recall otherwise
assisting with the record or the vaccination itself or otherwise interacting with petitioner
on May 23, 2016. Tr. 183-88.
• MA Guerrab testified that at Duke Primary Care, a nurse supervised and trained the
medical assistants, including on how to administer vaccines. MA Guerrab did not
remember this nurse’s name and believed that the nurse had left the practice. Tr. 169-71.
• MA Guerrab testified that in general, a Tdap vaccine should be given intramuscularly at a
90-degree angle. Tr. 173-75. The proper needle length is one inch, regardless of the
vaccinee’s size. Tr. 175-76; see also Pet. Ex. 31 at ¶ 1.
• MA Guerrab testified that for an MMR vaccine, the encouraged “best practice” is
subcutaneous administration, but an intramuscular administration would not be “the end
of… the world”. Tr. 176-77; see also Pet. Ex. 31 at ¶¶ 8-10. She stated that a
subcutaneous MMR vaccine should be given in the back of the arm, the fatty part, at a
45-degree angle. Tr. 178. She testified that the appropriate needle length is “one and a
half inches”, which she agreed would be “longer than the needle for the Tdap
vaccination.” Tr. 179.
10

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 11 of 13
• I have also reviewed the testimony of Amrit Gill, M.D., who confirmed that as part of her
day-to-day duties at Duke Primary Care, she will enter an order for a patient to receive
vaccine(s). Afterwards, Dr. Gill will not participate at all in the vaccinations or the
resulting records. She will leave the room and “be done with the patient essentially”.
She will notify a “nurse” that the patient needs the vaccine(s). The “nurse” will
administer the vaccine. Tr. 148-51.
• Dr. Gill confirmed that she established care of petitioner on May 23, 2016. She reviewed
petitioner’s medical records from that date forward. She did not have any recollections
of the encounter with petitioner outside of what was included in the medical records. Tr.
149-66.
C. Findings of Fact
I acknowledge that the medical records memorialize that petitioner’s May 23, 2016
MMR vaccine was intended for subcutaneous administration. Pet. Ex. 3 at 10; Pet. Ex. 29 at 7;
Pet. Ex. 9 at 2.
As noted in the legal standard above, in LaLonde, the Court outlined four possible
explanations for inconsistencies between contemporaneously created medical records and later
testimony: (1) a person’s failure to recount to the medical professional everything that happened
during the relevant time period; (2) the medical professional’s failure to document everything
reported to her or him; (3) a person’s faulty recollection of the events when presenting
testimony; or (4) a person’s purposeful recounting of symptoms that did not exist. La Londe,
110 Fed. Cl. at 203-04. This case likely presents an additional situation in which medical
records may be inaccurate. The records in question do not record events or symptoms that
occurred prior to the appointment, but rather, how a medical assistant with less than two months
of actual experience actually handled the uncommon administration of an MMR vaccine to an
adult. Under these circumstances, I find that petitioner’s Facebook posts in 2016 as well as the
testimony from the witnesses, particularly petitioner and her husband, should be accorded greater
weight than the medical records towards understanding how the MMR vaccine was actually
administered.
I specifically find that Dr. Amrit Gill ordered the Tdap and MMR vaccines. Dr. Gill
notified either a nurse or a medical assistant that the vaccines needed to be administered. That
task was assigned to Tracie Collins, who was licensed as a medical assistant in early 2016, was
hired for her first job at Duke Primary Care in April 2016, and was still being trained at the time
of petitioner’s appointment.
It is more likely than not that MA Collins selected the needle for the Tdap vaccine, since
she recorded all of the details and that she was the administrator. She could not state the
appropriate needle length but seemed to agree that it was something “standard”. Petitioner does
not allege that the Tdap vaccine, which was administered in her left arm, caused or contributed to
any injury. However, these facts go towards MA Collins’s degree of general knowledge about
proper vaccine administration.
11

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 12 of 13
It is less clear who selected the needle for the MMR vaccine, as the record reflects that
MA Guerrab entered many of the details, then MA Collins did the actual administration. See
Pet. Ex. 29 at 8. However, both individuals were incorrect about the appropriate needle length
for an MMR vaccine. MA Guerrab stated that it should be one and a half inches long. Tr. 179.
MA Collins testified that it should be the same length as for a Tdap vaccine. Tr. 119, 121.
Additionally, petitioner’s Facebook posts, as well as petitioner and her husband’s credible
testimony documented that another unidentified medical provider entered the room and
observed, in the moment that MA Collins was administering the MMR vaccine, that she was
using an incorrect needle. Thus, regardless of which individual selected the needle for the MMR
vaccine, it was more likely than not at least one inch long. This needle length is not appropriate
for a subcutaneous vaccine, but rather for an intramuscular vaccine. See Resp. Ex. E-29.
The witnesses consistently testified that no medical provider – such as Dr. Gill, the
supervising nurse, or MA Guerrab – supervised MA Collins’s administration of petitioner’s
vaccines. A medical assistant does not have the same level of training as a nurse or a doctor and
Ms. Collins was early in her career at the time at issue here.
MA Collins started by administering the Tdap vaccine into petitioner’s left arm. MA
Collins testified that in general, a Tdap vaccine should be administered into the biceps muscle at
a ninety-degree angle. She did not specifically remember petitioner’s vaccines on May 23, 2016,
when she had been working as a medical assistant for less than two months and was still being
trained. In contrast, petitioner and her husband testified credibly that MA Collins briefly left the
room and when she came back in, she had to be reminded to wash her hands and put on sterile
gloves. Tr. 8, 66-67. In addition, MA Collins was relatively shorter than petitioner (at 5”10’ and
sitting on the table) and she administered the Tdap vaccine upwards at an angle between thirty to
forty-five degrees. Tr. 67-68, 98-99. While this is not a dispositive fact, an intramuscular
vaccine should actually administered at a ninety-degree angle. See Resp. Ex. E-29.
MA Collins then administered the MMR vaccine into petitioner’s right arm. MA Collins
testified that in general, an MMR vaccine should be administered into the fat on the back of the
arm at a 45-degree angle. Tr. 117-19. However, she did not remember administering this
specific vaccine to petitioner. In contrast, petitioner and her husband testified credibly that in
between administering the Tdap and the MMR vaccines, MA Collins remembered to ask whether
petitioner could potentially be pregnant. Petitioner left the examination room to take a
pregnancy test. Petitioner then returned to the examination room and to her position on the table.
Dr. Gill came into state that the test was negative and then MA Collins resumed with the MMR
vaccination. Petitioner and her husband recalled that MA Collins stood in front of petitioner, so
that the three of them formed a triangle. Tr. 11, 71, 94. Petitioner testified credibly that MA
Collins pinched the skin on her arm to administer the MMR vaccine. Tr. 11. However, MA
Collins administered the MMR vaccine a little bit higher on the arm, compared to the Tdap
vaccine, based on where she placed the bandage. Tr. 12. Petitioner pointed at where the MMR
vaccine was administered on her arm, which I observed to be “roughly where the deltoid muscle
is” in the “upper middle lateral section of the arm”. Tr. 14. The husband testified credibly that
the MA Collins used the same upwards angle of between thirty to forty-five degrees for the
MMR vaccine. Tr. 67-68, 98-99. While MA Collins’s pinching of the skin and her chosen angle
12

Case 1:18-vv-00396-UNJ Document 80 Filed 02/17/21 Page 13 of 13
may have been appropriate for a subcutaneous vaccine, her position standing in front of
petitioner and her choice of the upper deltoid muscle area were not. See Resp. Ex. E-29.
While it is not surprising that petitioner and her husband had more specific recollections
the MMR vaccine’s administration and that the medical personnel had no specific recollection of
the appointment other than what they could read in the notes, the specific recollections of the
appointment and the correlation of the underlying injury with the description of petitioner were
consistent, clear, cogent, and compelling. Based on those specific recollections, I conclude that
it is more likely than not that MA Collins intended to give the MMR vaccine subcutaneously but
she did not, at that early stage of her career, understand where on the arm a subcutaneous vaccine
should be administered, the precise angle, or the length of needle that should be used.
Overall, the facts are less consistent with proper subcutaneous administration and more
consistent with unintended intramuscular administration of the MMR vaccine.
IV. Conclusion
In addition to the the above findings of fact concerning how the MMR vaccine was
administered, during the status conference on January 22, 2021, I noted that petitioner credibly
described a stabbing pain upon vaccination and she described significant pain that she had not
previously experienced thereafter. The anatomic location of the medial sling of the biceps
tendon in the proximal humerus between the greater and lesser tuberosities and the observation
that it was torn at the time of surgery, seems most consistent with an injection improperly given
at an upward angle in the central part of the proximal humerus. It also seems likely that the
adhesive capsulitis described and released under anesthesia by Dr. Wilson likely resulted from
pain-protective lack of movement of the right arm in the months following the MMR
vaccination.
In accordance with the above, the following is ORDERED:
1) Petitioner shall forward a reasonable demand to respondent and file a status report
confirming that she has done so within 30 days, by Friday, February 26, 2021.
2) Respondent shall file a status report proposing further proceedings within 30 days
thereafter.
IT IS SO ORDERED.
s/ Thomas L. Gowen
Thomas L. Gowen
Special Master
13

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_18-vv-00396-1
Date issued/filed: 2021-04-19
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 3/30/21) regarding 85 DECISION Stipulation/Proffer Signed by Special Master Thomas L. Gowen. (kb) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-00396-UNJ Document 89 Filed 04/19/21 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
Filed: March 30, 2021
* * * * * * * * * * * * * UNPUBLISHED
SABRINA CHAPPELL-STRICKLAND, *
* No. 18-396V
Petitioner, *
v. * Special Master Gowen
*
SECRETARY OF HEALTH * Stipulation; Measles-Mumps-Rubella
AND HUMAN SERVICES, * (MMR); Shoulder Injury Related to
* Vaccine Administration (SIRVA).
*
Respondent. *
* * * * * * * * * * * * *
Bridget C. McCullough, Muller Brazil, LLP, Dresher, PA, for petitioner.
Darryl R. Wishard, United States Department of Justice, Washington, D.C., for respondent.
DECISION ON STIPULATION1
On March 15, 2018, Sabrina Chappell-Strickland (“petitioner”), filed a petition for
compensation in the National Vaccine Injury Compensation Program.2 Petition (ECF No. 1).
Petitioner received a measle-mumps-rubella (“MMR”) vaccination, which is contained in the
Vaccine Injury Table, in her right arm on May 23, 2016. Petitioner alleges that as a result of
receiving the MMR vaccine, she suffered the onset of a right shoulder injury within the Table
timeframe, or alternatively, that the vaccine caused her right shoulder injury, and that she
experienced symptoms of the injury for more than six months.
On January 27, 2021, I issued formal Findings of Fact pertaining to the MMR vaccine’s
administration. Findings of Fact (ECF No. 78).
1
Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this opinion contains a
reasoned explanation for the action in this case, I intend to post it on the website of the United States Court of
Federal Claims. The Court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. Before the opinion
is posted on the Court’s website, each party has 14 days to file a motion requesting redaction “of any information
furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or
confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly
unwarranted invasion of privacy.” Vaccine Rule 18(b). An objecting party must provide the Court with a proposed
redacted version of the opinion. Id. If neither party files a motion for redaction within 14 days, the opinion will
be posted on the Court’s website without any changes. Id.
2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine
Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended 42 U.S.C. §§ 300aa-10 to 34 (2012)
(hereinafter “Vaccine Act” or “the Act”). Hereinafter, individual section references will be to 42 U.S.C. § 300aa of
the Act.

Case 1:18-vv-00396-UNJ Document 89 Filed 04/19/21 Page 2 of 7
On March 30, 2021, respondent filed a stipulation providing that a decision should be
entered awarding compensation to petitioner. Stipulation (ECF No. 84). Respondent denies that
petitioner sustained a Table injury, denies that the vaccine either caused or significantly
aggravated petitioner’s alleged injury or any other injury, and denies that petitioner’s current
disabilities are the result of a vaccine-related injury. Id. at ¶ 6. While maintaining their
respective positions, the parties nevertheless now agree that a decision should be entered
awarding the compensation described in paragraph 6 of the stipulation, which is attached hereto
as Appendix A. Id. at ¶ 7.
The stipulation awards a lump sum of $57,500.00 ($55,000.00 for pain and suffering,
and $2,500.00 for past unreimbursed expenses) in the form of a check payable to petitioner.
This amount represents compensation for all damages that would be available under 42 U.S.C. §
300aa-15(a).
I adopt the stipulation as the decision of the Court and hereby award compensation in the
amount and on the terms set forth therein. Accordingly, the Clerk of Court SHALL ENTER
JUDGMENT in accordance with the terms of the parties’ stipulation.3
IT IS SO ORDERED.
s/Thomas L. Gowen
Thomas L. Gowen
Special Master
3 Entry of judgment is expedited by each party’s filing notice renouncing the right to seek review. Vaccine Rule
11(a).
2

Case 1:18-vv-00396-UNJ Document 89 Filed 04/19/21 Page 3 of 7
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
)
SABRINA CHAPPELL-STRICKLAND, )
)
Petitioner, ) No. 18-396V ECF
)
V. ) Special Master Gowen
)
SECRETARY OF HEAL TH )
AND HUMAN SERVICES, )
)
Respondent. )
--------------)
STIPULATION
The pai1ies hereby stipulate to the following matters:
1. Petitioner, Sabrina Chappell-Strick.land, filed a petition for vaccine compensation
under the National Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-10 to 34 (the
"Vaccine Program"). The petition seeks compensation for injuries allegedly related to
petitioner's receipt of the measles-mumps-rubella ("MMR") vaccine, which is contained in the
Vaccine Injury Table (the "Table"), 42 C.F.R. § 100.3(a).
2. On May 23, 2016, petitioner received MMR vaccine in the right arm.
3. The vaccine was administered within the United States.
4. Petitioner alleges that, as a result of receiving the vaccine, she suffered the onset of a
right shoulder injury within the Table timeframe, or alternatively, that her vaccine caused her
right shoulder injury, and that she experienced symptoms of the injury for more than six months.
5. Petitioner represents that there has been no prior award or settlement of a civil action
for damages as a result of her alleged injuries.

Case 1:18-vv-00396-UNJ Document 89 Filed 04/19/21 Page 4 of 7
6. Respondent denies that petitioner sustained a Table injury, denies that the vaccine
either caused or significantly aggravated petitioner's alleged injury or any other injwy, and
denies that petitioner's current disabilities are the result of a vaccine-related injury.
7. Maintaining their above-stated positions, the parties nevertheless now agree that the
issues between them shall be settled and that a decision should be entered awarding the
compensation described in paragraph 8 of this Stipulation.
8. As soon as practicable after an entty ofj udgment reflecting a decision consistent
with the terms of this Stipulation, and after petitioner has filed an election to receive
compensation pursuant to 42 U.S.C. § 300aa-2l(a)(l), the Secretary of Health and Human
Services will issue the following vaccine compensation payment:
A lump sum of $57,500.00 ($55,000.00 for pain and suffering, and $2,500.00 for
past unreimbursed expenses), in the form of a check payable to petitioner. This
amount represents compensation for all damages that would be available under 42
U.S.C. § 300aa-15(a), including past unreimbursed expenses and pain and
suffering.
9. As soon as practicable after the entty of judgment on entitlement in this case, and
after petitioner has filed both a proper and timely election to receive compensation pursuant to
42 U.S.C. Section 300aa-2l(a)(l ), and an application, the parties will submit to further
proceedings before the special master to award reasonable attorneys' fees and costs incurred in
proceeding upon this petition.
I 0. Petitioner and her attorney represent that compensation to be provided pursuant to
this Stipulation is not for any items or services for which the Program is not primarily liable
under 42 U.S.C. § 300aa-15(g), to the extent that payment has been made or can reasonably be
expected to be made under any State compensation programs, insurance policies, Federal or
2

Case 1:18-vv-00396-UNJ Document 89 Filed 04/19/21 Page 5 of 7
State health benefits programs (other than Title XIX of the Social Security Act (42 U.S.C.
§ 1396 et seq.)), or by entities that provide health services on a pre-paid basis.
11. Payment made pursuant to paragraph 8 of this Stipulation, and any amounts
awarded pursuant to paragraph 9 of this Stipulation, will be made in accordance with 42 U.S.C.
§ 300aa-15(i), subject to the availability of sufficient statutory funds.
12. The parties and their attorneys further agree and stipulate that, except for any award
for attorneys' fees and litigation costs, and past wrreimbursed expenses, the money provided
pursuant to this Stipulation will be used solely for the benefit of petitioner, as contemplated by a
strict construction of 42 U.S.C. § 300aa-15(a) and (d), and subject to the conditions of 42 U.S.C.
§§ 300aa-15(g) and (h).
13. In return for the payments described in paragraphs 8 and 9, petitioner, in her
individual capacity and on behalf of her heirs, executors, administrators, successors or assigns,
does forever irrevocably and unconditionally release, acquit and discharge the United States and
the Secretary of Health and Human Services from any and all actions, causes of action (including
agreements, judgments, claims, damages, loss of services, expenses and all demands of whatever
kind or nature) that have been brought, could have been brought, or could be timely brought in
the Court of Federal Claims, under the National Vaccine Injury Compensation Program, 42
U.S.C. § 300aa-10 et seq., on account of, or in any way growing out of, any and all known or
unknown, suspected or unsuspected personal injuries to or death of petitioner resulting from, or
alleged to have resulted from, the vaccine administered on May 23, 2016, as alleged by petitioner
in a petition for vaccine compensation filed on or about March 15, 2018, in the United States
Court of Federal Claims as petition No. 18-396V.
3

Case 1:18-vv-00396-UNJ Document 89 Filed 04/19/21 Page 6 of 7
14. If petitioner should die prior to entry of judgment, this agreement shall be voidable
upon proper notice to the Court on behalf of either or both of the pai1ies.
15. If the special master fails to issue a decision in complete confonnity with the te1ms
of this Stipulation or if the Court of Federal Claims fails to enter judgment in conformity with a
decision that is in complete confonnity with the terms of this Stipulation, then the parties'
settlement and this Stipulation shall be voidable at the sole discretion of either party.
16. TI1is Stipulation expresses a full and complete negotiated settlement of liability and
damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except
as otherwise noted in paragraph 9 above. There is absolutely no agreement on the part of the
parties hereto to make any payment or to do any act or thing other than is herein expressly stated
and clearly agreed to. The parties fut1her agree and understand that the award described in this
stipulation may reflect a compromise of the parties' respective positions as to liability and/or
amount of damages, and futther, that a change in the nature of the injury or condition or in the
items of compensation sought, is not grounds to modify or revise this agreement.
17. This Stipulation shall not be construed as an admission by the United States or the
Secretary of Health and Human Services that petitioner sustained a Table injury, or that the
vaccine either caused or significantly aggravated petitioner's alleged injury or any other injury.
18. All rights and obligations of petitioner hereunder shall apply equally to petitioner's
heirs, executors, administrators, successors, and/or assigns.
END OF STIPULATION
4

Case 1:18-vv-00396-UNJ Document 89 Filed 04/19/21 Page 7 of 7
Respectfully submitted,
PETITIONER:
. / c ......
. I
v--, I .. -·· - -.i,,
'\ ,,.____>.,__~ --------
'' .• .
SABReyA CHAPPELL-STRICKLAND
ATTORNEY OF RECORD FOR AUTHORIZED REPRESENTATIVE
PETITIONER: OF THE ATTORNEY GENERAL:
~'-L/\~9i7
~
HEATHER L. PEARLMAN
Acting Deputy Director
Torts Branch
Civil Division
U.S. Department of Justice
P.O. Box 146
Benjamin Franklin Station
Washington, DC 20044-0146
AUTHORIZED REPRESENTATIVE ATTORNEY OF RECORD FOR
OF THE SECRETARY OF HEAL TH RESPONDENT:
AND HUMAN SERVICES:
~ R.. L,U~~.)
CAPTv& ~ , v#Sc.-, ~~ b-...f l;je~LV~~
TAMARA OVERBY () DARRYL R. WISHARD
Acting Director, Division of Injury Assistant Director
Compensation Programs Torts Branch
Healthcare Systems Bureau Civil Division
U.S. Department of Health U.S. Department of Justice
and Human Services P.O. Box 146
5600 Fishers Lane, 08Nl46B Benjamin Franklin Station
Rockville, MD 20857 Washington, DC 20044-0146
Tel: (202) 616-4357
danyl.wishard@usdoj.gov
03 f.30/zoz I
Dated:
5